Forensic Audit Report: Federal Enforcement Actions Targeting Fraudulent and Adulterated Honey Markets (2013–2025 FY)

U.S. Honey Importation and Domestic Distribution Channels & Economically Motivated Adulteration (EMA), Tariff Evasion, and Mislabeled Chinese-Origin Honey

Executive Summary

This forensic audit report reviews the coordinated enforcement efforts of the U.S. Department of Justice (DOJ)and the Food and Drug Administration (FDA)to combat illegal activities within the global and domestic honey market. Honey is consistently identified as one of the most adulterated foods in the world. The investigation focuses on two distinct yet interrelated issues: the criminal evasion of anti-dumping duties via transshipment and mislabeling, and the detection of economically motivated adulteration (EMA)

—specifically, the dilution of honey with cheap sugar syrups and contamination with unapproved antibiotics. Data indicates that while significant criminal penalties were applied in major historical cases, the regulatory detection of adulterated imports remains a persistent requirement.

Methodology

The scope of this audit covers enforcement activities from 2013 through the FDA’s projected 2025 Fiscal Year (FY) assignments. It utilizes enforcement data provided by the DOJ and FDA to trace the pathways of fraudulent products and assess the scale of tariff evasion. Additionally, testing parameters and agricultural baselines were cross-referenced with data from USDA FoodData Central

Findings of Fact: DOJ Criminal Enforcement Actions

Investigations by the Department of Justice

confirm major schemes orchestrated to evade anti-dumping duties on Chinese-origin honey and distribute adulterated products within the United States.

Major Corporate Conspiracy Case (2013)

The DOJ charged two major commercial companies and five individuals following a nationwide investigation into the illegal importation of honey from China.

• Fraudulent Modus Operandi: The schemers mislabeled Chinese honey to declare a different origin, successfully avoiding required anti-dumping duties.
• Adulteration and Contamination: Testing revealed the product was adulterated with chloramphenicol, an unapproved veterinary antibiotic.
• Financial Impact: The scheme allegedly avoided over $180 million in legally required duties.
• Enforcement Outcome: Honey Holding, Inc. (doing business as Honey Solutions) and Groeb Farms both entered deferred prosecution agreements, accepted financial penalties, and were mandated to implement compliance programs.

California Broker Tariff Evasion (2013)

In a separate action, a California honey broker, Hung Yi Lin, was targeted for fraudulent customs declarations.

• Fraudulent Modus Operandi: Lin falsely declared hundreds of shipping containers of Chinese-origin honey as “sugars” and “syrups.”
• Financial Impact: This misclassification scheme resulted in the evasion of $39.2 million in tariffs.
• Enforcement Outcome: Hung Yi Lin was sentenced to three years in federal prison.

Findings of Fact: FDA Surveillance and Adulteration Detection

The FDA plays the critical role of detecting EMA, defined as the intentional addition of cheaper sweeteners (such as corn syrup, rice syrup, or cane sugar) to honey to maximize profits. A review of FDA surveillance data for imported honey shows fluctuating violation rates:

FDA Sampling Data (Imported Honey)

Regulatory Response

When the FDA detects a violative sample, the following regulatory actions are taken immediately:

• Refusal of entry into the United States.
• Placement of the offending company or product on Import Alert 99-47, facilitating detention without physical examination of future shipments.

Future Scope (2025 FY)

To better assess the purity of the marketplace, the FDA’s 2025 FY assignment has officially expanded its testing scope to include both imported and domestic honey products

.

Evolution of Authenticity Testing Protocols

To detect food fraud effectively, laboratories must utilize multiple screening methodologies. Historically, the FDA and the honey industry have relied on the SCIRA test (AOAC method 998.12). This test effectively detects added C4 sugar syrups obtained from corn and cane sugar. However, it does not detect C3 sugar syrups, such as those derived from beet, rice, or wheat.

To close this detection gap, the National Honey Packers and Dealer’s Association (NHPDA)

is working with the FDA to develop advanced C3 adulteration testing. Currently, the most sophisticated screening method is referred to as “State of the Art” (SOTA) testing. Endorsed by the majority of contract labs, this three-test approach includes:

• EA/LC-IRMS: 13C Stable Carbon Isotope Ratio method paired with a liquid chromatograph.
• NMR: H1 Nuclear Magnetic Resonance Profiling.
• HRMS: Liquid Chromatography-High Resolution Mass Spectrometry.

Industry and Policy Implications

A review of the industry context shows that the lack of a standardized legal definition of honey creates vulnerabilities that facilitate fraud. Currently, the Agricultural Marketing Service (AMS)

U.S. Grade A extracted honey must meet applicable requirements and achieve a minimum total score of 90 points. However, AMS grading does not provide an anti-fraud legal definition.

• Current Deficiency: The U.S. currently lacks a comprehensive federal “Standard of Identity” for honey.
• Proposed Resolution: U.S. honey producers are advocating for Congress to establish this standard, modeled on the international Codex Alimentarius.
• Expected Benefits: A clear standard would legally define what constitutes “honey,” set strict limits on additives and contaminants, and provide an enforceable metric to combat misbranding, EMA, and fraudulent labeling.

Audit Conclusion

The combined evidence indicates that the U.S. honey market remains a lucrative target for international fraud, primarily driven by the desire to evade anti-dumping duties on Chinese products and increase profit margins through adulteration with cheap syrups.

Criminal prosecutions by the DOJ

have successfully targeted major conspirators, proving that tariff evasion and antibiotic contamination were occurring on a massive financial scale exceeding $180 million. FDA data shows that EMA remains a persistent threat among imported products, with a 10% violation rate recorded as recently as 2022. The regulatory approach is now shifting toward a more comprehensive market survey—including domestic products—supported by advanced SOTA testing methodologies.

Ultimately, industry advocates maintain that a federal Standard of Identity is required as a final backstop to prevent continued misbranding and protect supply chain integrity

.

.

Frequently Asked Questions: Honey Authenticity, Processing, and Safety